N

Nanjing Vazyme Biotech Co Ltd
SSE:688105

Watchlist Manager
Nanjing Vazyme Biotech Co Ltd
SSE:688105
Watchlist
Price: 23.06 CNY -2.45% Market Closed
Market Cap: 9.3B CNY
Have any thoughts about
Nanjing Vazyme Biotech Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Nanjing Vazyme Biotech Co Ltd stock under the Base Case scenario is 23.35 CNY. Compared to the current market price of 23.06 CNY, Nanjing Vazyme Biotech Co Ltd is Undervalued by 1%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
23.35 CNY
Undervaluation 1%
Intrinsic Value
Price
N
Worst Case
Base Case
Best Case

Valuation History
Nanjing Vazyme Biotech Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for Nanjing Vazyme Biotech Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about Nanjing Vazyme Biotech Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

23.06 CNY
-2.45%
-2.45%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Nanjing Vazyme Biotech Co Ltd
CN
Biotechnology
Market Cap
9.1B CNY
IPO
Nov 15, 2021
Employees
1 409
China
Market Cap
9.1B CNY
Industry
Biotechnology
IPO
Nov 15, 2021
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Nanjing Vazyme Biotech Co Ltd

Provide an overview of the primary business activities
of Nanjing Vazyme Biotech Co Ltd.

What unique competitive advantages
does Nanjing Vazyme Biotech Co Ltd hold over its rivals?

What risks and challenges
does Nanjing Vazyme Biotech Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Nanjing Vazyme Biotech Co Ltd.

Provide P/S
for Nanjing Vazyme Biotech Co Ltd.

Provide P/E
for Nanjing Vazyme Biotech Co Ltd.

Provide P/OCF
for Nanjing Vazyme Biotech Co Ltd.

Provide P/FCFE
for Nanjing Vazyme Biotech Co Ltd.

Provide P/B
for Nanjing Vazyme Biotech Co Ltd.

Provide EV/S
for Nanjing Vazyme Biotech Co Ltd.

Provide EV/GP
for Nanjing Vazyme Biotech Co Ltd.

Provide EV/EBITDA
for Nanjing Vazyme Biotech Co Ltd.

Provide EV/EBIT
for Nanjing Vazyme Biotech Co Ltd.

Provide EV/OCF
for Nanjing Vazyme Biotech Co Ltd.

Provide EV/FCFF
for Nanjing Vazyme Biotech Co Ltd.

Provide EV/IC
for Nanjing Vazyme Biotech Co Ltd.

Show me price targets
for Nanjing Vazyme Biotech Co Ltd made by professional analysts.

What are the Revenue projections
for Nanjing Vazyme Biotech Co Ltd?

How accurate were the past Revenue estimates
for Nanjing Vazyme Biotech Co Ltd?

What are the Net Income projections
for Nanjing Vazyme Biotech Co Ltd?

How accurate were the past Net Income estimates
for Nanjing Vazyme Biotech Co Ltd?

What are the EPS projections
for Nanjing Vazyme Biotech Co Ltd?

How accurate were the past EPS estimates
for Nanjing Vazyme Biotech Co Ltd?

What are the EBIT projections
for Nanjing Vazyme Biotech Co Ltd?

How accurate were the past EBIT estimates
for Nanjing Vazyme Biotech Co Ltd?

Compare the revenue forecasts
for Nanjing Vazyme Biotech Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Nanjing Vazyme Biotech Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Nanjing Vazyme Biotech Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Nanjing Vazyme Biotech Co Ltd compared to its peers.

Compare the P/E ratios
of Nanjing Vazyme Biotech Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Nanjing Vazyme Biotech Co Ltd with its peers.

Analyze the financial leverage
of Nanjing Vazyme Biotech Co Ltd compared to its main competitors.

Show all profitability ratios
for Nanjing Vazyme Biotech Co Ltd.

Provide ROE
for Nanjing Vazyme Biotech Co Ltd.

Provide ROA
for Nanjing Vazyme Biotech Co Ltd.

Provide ROIC
for Nanjing Vazyme Biotech Co Ltd.

Provide ROCE
for Nanjing Vazyme Biotech Co Ltd.

Provide Gross Margin
for Nanjing Vazyme Biotech Co Ltd.

Provide Operating Margin
for Nanjing Vazyme Biotech Co Ltd.

Provide Net Margin
for Nanjing Vazyme Biotech Co Ltd.

Provide FCF Margin
for Nanjing Vazyme Biotech Co Ltd.

Show all solvency ratios
for Nanjing Vazyme Biotech Co Ltd.

Provide D/E Ratio
for Nanjing Vazyme Biotech Co Ltd.

Provide D/A Ratio
for Nanjing Vazyme Biotech Co Ltd.

Provide Interest Coverage Ratio
for Nanjing Vazyme Biotech Co Ltd.

Provide Altman Z-Score Ratio
for Nanjing Vazyme Biotech Co Ltd.

Provide Quick Ratio
for Nanjing Vazyme Biotech Co Ltd.

Provide Current Ratio
for Nanjing Vazyme Biotech Co Ltd.

Provide Cash Ratio
for Nanjing Vazyme Biotech Co Ltd.

What is the historical Revenue growth
over the last 5 years for Nanjing Vazyme Biotech Co Ltd?

What is the historical Net Income growth
over the last 5 years for Nanjing Vazyme Biotech Co Ltd?

What is the current Free Cash Flow
of Nanjing Vazyme Biotech Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Nanjing Vazyme Biotech Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Nanjing Vazyme Biotech Co Ltd

Current Assets 3.5B
Cash & Short-Term Investments 2.6B
Receivables 499m
Other Current Assets 407.7m
Non-Current Assets 1.5B
Long-Term Investments 52.3m
PP&E 777.3m
Intangibles 227.6m
Other Non-Current Assets 435.8m
Current Liabilities 763.4m
Accounts Payable 89.7m
Accrued Liabilities 82.3m
Short-Term Debt 492.2m
Other Current Liabilities 99.2m
Non-Current Liabilities 239m
Long-Term Debt 172.4m
Other Non-Current Liabilities 66.7m
Efficiency

Earnings Waterfall
Nanjing Vazyme Biotech Co Ltd

Revenue
1.4B CNY
Cost of Revenue
-417.9m CNY
Gross Profit
984.7m CNY
Operating Expenses
-1.1B CNY
Operating Income
-66.4m CNY
Other Expenses
90m CNY
Net Income
23.6m CNY

Free Cash Flow Analysis
Nanjing Vazyme Biotech Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Nanjing Vazyme Biotech Co Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Year Average ROIC
Exceptional Revenue Growth Forecast
Positive Net Income
50/100
Profitability
Score

Nanjing Vazyme Biotech Co Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Nanjing Vazyme Biotech Co Ltd's solvency score is 86/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
86/100
Solvency
Score

Nanjing Vazyme Biotech Co Ltd's solvency score is 86/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Nanjing Vazyme Biotech Co Ltd

Wall Street analysts forecast Nanjing Vazyme Biotech Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Nanjing Vazyme Biotech Co Ltd is 25.14 CNY with a low forecast of 22.51 CNY and a high forecast of 28.35 CNY.

Lowest
Price Target
22.51 CNY
2% Downside
Average
Price Target
25.14 CNY
9% Upside
Highest
Price Target
28.35 CNY
23% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Nanjing Vazyme Biotech Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Nanjing Vazyme Biotech Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

See Also

Discover More
What is the Intrinsic Value of one Nanjing Vazyme Biotech Co Ltd stock?

The intrinsic value of one Nanjing Vazyme Biotech Co Ltd stock under the Base Case scenario is 23.35 CNY.

Is Nanjing Vazyme Biotech Co Ltd stock undervalued or overvalued?

Compared to the current market price of 23.06 CNY, Nanjing Vazyme Biotech Co Ltd is Undervalued by 1%.

Back to Top